Abstract
Heart failure is a highly prevalent disease in western society. Drug therapies aimed at increasing myocardial contractility have been associated with decreased survival. Several short and mid term clinical studies have suggested adjuvant or alternative therapies to congestive heart failure using modified pacing techniques that were aimed to increase contractility (e.g. Paired pacing) or restore synchrony of contraction (biventricular pacing). While delivery of paired pacing was abandoned during the early 70's, biventricular pacing has recently emerged as an adjuvant treatment to limited group of congestive heart failure patients with aberrant left ventricular conduction. In this brief review, we describe our initial safety and efficacy experience in patients with heart failure using a novel non-stimulatory electrical approach to the delivery of positive inotropic therapy to the failing myocardium. The study suggests that unlike modified pacing techniques, delivery of the signal to the left ventricle during the refractory period resulted in a rapid increase in myocardial contractility and improved hemodynamic performance. The near instantaneous contractility improvement achieved by this type of stimulus was shown to be safe and effective independently of the primary cause of heart failure or the function of the conduction system. Unlike pharmacologic treatments, which have a relatively constant effect, use of electrical stimuli may prove useful as a new therapeutic modality in the treatment of heart failure with which contractility can be improved when and as needed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sutton GC. Epidemiologic aspects of heart failure. Am Heart J 1990;120:1538–1540.
Smith WM. Epidemiology of congestive heart failure. Am J Cardiol 1985;55:3–8A.
The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293–302.
The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive failure: Results of the cooperative North Scandinavian enalapril survival study (Consensus). N Engl J Med 1987;316:1429–1435. Fig. 3. Echocardiograpic traces of septal wall motion. Septal wall motion velocity in a patient with idiophatic cardiomyopathy (EF 20%) was measured using echo doppler. CCM signal was delivered to the Anterior interventricular vein (GCV). Motion before delivering the CCM signal (upper trace) was compared to motion when CCM signal was applied (lower trace). A visible improvement of septal movement is demonstrated during CCM delivery. Fig. 4. Relationship between atrio-ventricular (AV) pacing delay and the increase in left ventricular peak dp=dt during CCM application. There is no apparent relation between AV delay and increase in contractility (Pà0.483 NS). Fig. 5. Change in the rate of arrhythmias during CCM delivery: Rate of arrhythmias was assessed at baseline, during, and after the delivery of CCM signal. Rate of arrhythmias signiÆcantly decreased (P<0.05) during the delivery of CCM and returned to approximately baseline level after the signal was turned off. Arrhythmia rate was calculated as the number of ectopic beats per 1000 heart beats. Fig. 2. Average effect of CCM signal: Bar graphs showing the average change (_SE) in peak left ventricular systolic pressure (top), peak left ventricular á dP=dt (second panel) and aortic pulse pressure (bottom panel) during DDD pacing alone and during DDD pacing combined with CCM signal. Left ventricular dp=dt increased from 1158_68.9mmHg=sec to 1261_76.1mmHg=sec. LV systolic pressure increased from 124.5_6.2mmHg to 135.5_6.3mmHg and pulse pressure increased from 48.5_5.3mmHg to 54.1_5.4mmHg. All changes were signiÆcant (p<0.05). Electrical Modulation of Cardiac Contractility 59
Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with hydralazine-isosorbide denitrate in the treatment of chronic congestive heart failure. N Eng J Med 1991; 325:303–310.
Packer M. Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope. J Am Coll Cardiol 1988;12:299–317.
Packer M, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Eng J Med 1991; 325:1468–1475.
Packer M. The development of positive inotropic agents for chronic heart failure: How have we gone astray? J Am Coll Cardiol 1993;22:119A-126A.
De Keulenaer GW, Brutsaert DL. Pathogenesis of heart failure. Changing conceptual paradigms. Acta Cardiol 1998;53(3):131–141.
Mann DL. Basic mechanisms of disease progression in the failing heart: The role of excessive adrenergic drive. Prog Cardiovasc Dis. 1998;41(1 Suppl 1):1–8.
Packer M. Beta-adrenergic blockade in chronic heart failure: Principles, progress, and practice. Prog Cardiovasc Dis 1998;41(1 Suppl 1):39–52.
Langendorf O. Untersuchungen am überlebenden Saugetierherzen. III. Abhandlung, Vorübergehende Unregelmässigkeiten des Herzschlages und ihre Ausgliechung. Pflugger Arch Physiol 1898;70:473–486.
King AJ, Taylor DE. The inotropic action of paired pulse stimulation in the normal and failing heart: An experimental study. Cardiovasc Res 1968;2:122–129.
Hoffman B, Bartelstone H., Scherlag B, Carnefield P. Effects of postextrasystolic potentiation on normal and failing hearts. Bull N Y Acad Med 1965;41:498–534.
Cooper MW. Postextrasystolic potentiation. Do we really know what it means and how to use it? Circulation. 1993; 88: 2962–2971.
Etienne Y, Mansourati J, Gilard M, Valls-Bertault V, Boschat J, Benditt DG, Lurie KG, Blanc JJ. Evaluation of left ventricular based pacing in patients with congestive heart failure and atrial fibrillation. Am J Cardiol 1999;83:1138–1140.
Pak PH, Maughan WL, Baughman KL, Kieval RS, Kass DA. Mechanism of acute mechanical beneÆt from VDD pacing in hypertrophied heart: Similarity of responses in hypertrophic cardiomyopathy and hypertensive heart disease. Circulation 1998;98:242–248.
Hochleitner M, Hortnagl H, Ng CK, Gschnitzer F, Zechmann W. Usefulness of physiologic dual chamber pacing in drug resistant idiopathic dilated cardiomyopathty. Am J Cardiol 1990;70:1320–1325.
Fananapazir L, Epstein ND, Curiel RV. Long term results of dual chamber (DDD) pacing in obstructive hyperthrophic cardiomyiopathy. Evidence for progressive and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994;90: 2731–2742.
Auricchio A, Klein H, Tockman B, Sack S, Stellbrink C, Neuzner J, Kramer A, Ding J, Pochet T, Maarse A, Spinelli J. Transvenous biventricular pacing for heart failure: Can the obstacles be overcome? Am J Cardiol1999;83:136D-142D.
Kaas DA, Chen-Huan C, Curry C, Talbot M, Berger R, Fetics B, Nevo E. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999;99:1567–1573. 22. Nishimura RA, Hayes DL, Holmes DR Jr, Tajik AJ. Mechanism of hemodynamic improvement by dual chamber pacing for severe left ventricular dysfunction: An acute Doppler and catheterization hemodynamic study. J Am Coll Cardiol 1995;25:281±288. 23. Lister JW, Klotz KH, Jomain SL, Stuckey JH, Hoffman BF. Effect of pacemaker site on cardiac output and ventricular activation in dogs with complete heart block. Am J Cardiol 1964;14:494±503. 24. Prinzen FW, Augustijn CH, Allesie, MA, et al. The time sequence of electrical and mechanical activation during spontaneous beating and ectopic stimulation. Eur Heart J 1992;13:535±543. 25. Chirife R, Ortega F, Salazar. Nonphysiological left heart AV intervals as a result of DDD and AAI `physiological' pacing. 1991;14:1752±1754. 26. Foster AH, Gold, MR, McLaughlin JS. Acute hemodynamic effects of atrio-biventricular pacing in humans. Ann Thorac Surg 1995;59:294±300. 27. Prutchi D, Mika Y, Snir Y, Ben-Arie J, Darvish N, Kimchy Y. An implanatable device to enhance cardiac contracility through non-excitatory signals. Circulation 1999;100 Supp. 1:1±122 28. Sabbah HN, Mika Y, Aviv R, Haddad W, Darvish N, Ben Haim S, Chaudhry P, Mishima T, Goldstein S. Delivery of non-excitatory contractility-modulation electric signals improve left ventricular perfomance in dogs with heart failure. Circulation 1999;100 Supp. 1:1±300 60 Pappone et al.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pappone, C., Vicedomini, G., Salvati, A. et al. Electrical Modulation of Cardiac Contractility: Clinical Aspects in Congestive Heart Failure. Heart Fail Rev 6, 55–60 (2001). https://doi.org/10.1023/A:1009807309006
Issue Date:
DOI: https://doi.org/10.1023/A:1009807309006